OpGen, Inc. (OTC:OPGN – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $72.26 and last traded at $72.26, with a volume of 674413 shares changing hands. The stock had previously closed at $28.00.
OpGen Trading Up 6.5%
The stock has a market cap of $302.03 million, a P/E ratio of -5.38 and a beta of -1.77. The business’s fifty day simple moving average is $17.64 and its 200 day simple moving average is $8.00.
OpGen Company Profile
OpGen, Inc (NASDAQ: OPGN) is a precision medicine company specializing in molecular diagnostics and digital solutions for infectious disease management. Leveraging next-generation sequencing, bioinformatics and molecular assay technologies, OpGen develops tools designed to detect microbial pathogens and antimicrobial resistance markers rapidly and accurately. The company’s mission is to support clinicians and laboratories in making timely, informed treatment decisions that help curb the spread of drug-resistant infections.
Among OpGen’s key offerings is the Acuitas® AMR Gene Panel, a suite of molecular assays that identify genetic determinants of antibiotic resistance directly from positive blood cultures.
Further Reading
- Five stocks we like better than OpGen
- Think You Missed Silver? You’re Wrong. Here’s Why.
- Your Bank Account Is No Longer Safe
- What a Former CIA Agent Knows About the Coming Collapse
- Silicon Valley insiders hint at 12-month AI warning
- Buy This Stock Now
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
